Ignite Creation Date:
2024-05-06 @ 5:56 PM
Last Modification Date:
2024-10-26 @ 2:38 PM
Study NCT ID:
NCT05489887
Status:
RECRUITING
Last Update Posted:
2024-04-08
First Post:
2022-08-04
Brief Title:
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Sponsor:
Giselle Sholler
Organization:
Milton S Hershey Medical Center
Organization Data
Organization:
Milton S Hershey Medical Center
Class:
OTHER
Study ID:
BCC018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Giselle Sholler
Lead Sponsor Class:
OTHER
Responsible Party:
Giselle Sholler
Responsible Party Title:
Beat Childhood Cancer Chair
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Milton S Hershey Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Y-mAbs | UNKNOWN |